-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UNe5+2NRdYDPETiOZ38jYmIn6GiO1WXcBjoyOP8DwzjgaE0xdn/mVBzhDgwozwYA kbMgYRJNd6WtZnhMmn5vMw== 0001209191-04-016715.txt : 20040319 0001209191-04-016715.hdr.sgml : 20040319 20040319165041 ACCESSION NUMBER: 0001209191-04-016715 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040317 FILED AS OF DATE: 20040319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWNE G MORGAN CENTRAL INDEX KEY: 0001111363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 04680493 BUSINESS ADDRESS: STREET 1: 111 W. 57TH STREET STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10019 MAIL ADDRESS: STREET 1: 111 W. 57TH STREET STREET 2: SUITE 1100 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0201 4 2004-03-17 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001111363 BROWNE G MORGAN C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 1 0 0 0 Common Stock 2004-03-17 4 A 0 971.0000 A 23868.0000 D Stock Option (Right to Buy) 38.6100 2004-03-17 4 A 0 7500.0000 A 2005-03-17 2014-03-16 Common Stock 7500.0000 7500.0000 D Reflects a grant of restricted stock under the Stock Purchase Plan for Non-Employee Directors, which vests over one-year in equal monthly increments and any unvested shares are subject to forfieture upon termination of the director's services prior to the end of the one-year term. The grant is exempt under Rule 16b-3. Includes 400 shares owned indirectly by Mr. Browne's wife. One third of the stock option becomes exercisable one year after the date of the grant and the remainder vests ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2004-03-19 -----END PRIVACY-ENHANCED MESSAGE-----